Briacell Therapeutics Corp WT
(NQ:
BCTXW
)
0.2854
-0.0560 (-16.40%)
Streaming Delayed Price
Updated: 3:58 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,770
Open
0.3113
Bid (Size)
0.2576 (1)
Ask (Size)
0.3145 (1)
Prev. Close
0.3414
Today's Range
0.2705 - 0.3670
52wk Range
0.1055 - 2.600
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BriaCell Therapeutics' Mission: Destroy Breast & Prostate Cancers
January 18, 2023
From my analysis of BriaCell, it would make a great buy and hold investment. If, and when, it is bought out by a major pharmaceutical company, or brings a product directly to market itself, its stock...
Via
Talk Markets
BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT(TM) Combination in Advanced Metastatic Breast Cancer
January 18, 2023
Registration study success could lead to a Biologics License Application (BLA) submission and commercialization approvals for BriaCell’s novel immunotherapy approach.
Via
Talk Markets
Performance
YTD
-88.11%
-88.11%
1 Month
+70.90%
+70.90%
3 Month
-47.15%
-47.15%
6 Month
-84.74%
-84.74%
1 Year
-87.96%
-87.96%
More News
Read More
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 14, 2022
Via
News Direct
Topics
Death
Exposures
Death
BriaCell’s Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 14, 2022
Via
TheNewswire.com
Topics
Death
Exposures
Death
BriaCell's Positive Clinical And Quality Of Life Data In Advanced Metastatic Breast Cancer Could Provide Hope For Patients
December 13, 2022
Via
Benzinga
BriaCell's Lead Candidate Bria-IMT™ Shows Promising Results For Advanced Breast Cancer Patients
December 01, 2022
Via
Benzinga
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies
November 30, 2022
From
ImmunoPrecise Antibodies
Via
Business Wire
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
August 16, 2021
From
Stock News Now
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.